Daewoong Pharmaceutical’s 34th domestically produced new drug, ‘Fexuclu’, is expanding rapidly globally. Daewoong Pharmaceutical announced on the 16th that Fexuclu, a treatment for gastroesophageal reflux disease, has entered the market or is about to enter the market in 24 countries, including Korea, just one year and six months on after launch. As of February 2024, […]
The post Daewoong Pharmaceutical’s Fexuclu: A Global Success Story appeared first on News Directory 3.
technology today: 2024-05-03 05:07:00
May 3, 2024
No Comments